• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM Back to Search Results
Catalog Number S-60-150-120-P6
Device Problems Difficult to Remove (1528); Material Separation (1562); Stretched (1601); Improper or Incorrect Procedure or Method (2017); Activation Failure (3270)
Patient Problem Vessel Or Plaque, Device Embedded In (1204)
Event Date 07/25/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).Evaluation summary: visual and functional inspections were performed on the returned device.The deployment issue, difficulty removing and stent elongation was not confirmed.The tip detachment was confirmed.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot did not indicate a lot specific product issue.The supera instructions for use states: should unusual resistance be felt at any time during stent deployment the entire system should be removed together with the introducer sheath or guiding catheter as a single unit.In this case, circumstances related to the deployment issue resulted in the need for further intervention and force in the attempt to remove the device.The investigation determined the reported difficulties were due to case circumstances.It is likely that the distal shaft was entrapped or restricted within the anatomy such that the ratchet was unable to engage the remainder of the stent for full deployment resulting in difficulty removing, stent elongation and tip detachment.The damage noted to the distal sheath may also indicate that the distal sheath was entrapped contributing to the deployment issue.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event Description
It was reported that the procedure was to treat a lesion in the superficial femoral artery (sfa) with no tortuosity and moderate calcification.A 6.0x150 mm supera self expanding stent system (sess) was advanced via the anterior tibial artery.On deploying the stent, the last 2cm of the stent failed to deploy.The thumbslide would move freely but the ratchet would not catch anymore stent to deploy.After repeated attempts to deploy the stent using the thumbslide, the handle was manually broken to attempt to deploy the stent without the handle.The stent did not deploy further.Stent elongation was noted when force was applied to withdraw the sess against resistance from the anatomy.As a result, posterior tibial artery access was gained and a 6.0 x 200 mm armada 18 percutaneous balloon angioplasty (pta) balloon catheter was advanced distal to the stent.While the balloon was inflated distal to the stent, the sess was removed with force and the stent fully deployed at the target lesion.A tip separation of the sess occurred.The separated tip remained in the diseased lesion distal to the stent.An additional unspecified supera stent was deployed distally via posterior tibial artery access with slight overlap to the implanted stent.The additional stent crushed the separated tip of the sess against the diseased vessel wall and successfully completed the procedure.The procedure was delayed by 60 minutes.There was no reported adverse patient sequela.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key7794466
MDR Text Key117564938
Report Number2024168-2018-06344
Device Sequence Number1
Product Code NIP
UDI-Device Identifier08717648211843
UDI-Public08717648211843
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial
Report Date 08/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/17/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/29/2020
Device Catalogue NumberS-60-150-120-P6
Device Lot Number8030761
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/09/2018
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/25/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/01/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-